ASP Isotopes Inc ASPI
π Company Profile
| Industry | Chemicals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-11-10 |
| Shares Out. | 149,060,000 |
| Website | aspisotopes.com/ β |
| Phone | 12027562245 |
| Employees | 271 |
| Revenue | $4.2M |
| Gross Profit | $1.7M |
| Net Income | -$26.7M |
| Free Cash Flow | -$65.8M |
| Total Assets | $587.7M |
| Total Liabilities | $288.7M |
| Equity | $299.0M |
About ASP Isotopes Inc
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
ASP Isotopes Inc is a publicly traded company under the ticker symbol ASPI on the NASDAQ NMS - GLOBAL MARKET, operating in the Chemicals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
9 analysts (2026-07-01)

